Esperion Therapeutics, Inc. (ESPR)


Esperion Therapeutics, Inc. (ESPR)

$36.56 USD

0.18 (-0.49%)

Updated Sep 13 12:00am

Add ESPR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

ESPR Daily Price Range
ESPR 52-Week Price Range

ESPR Stock Chart More Charts


ESPR Price/Volume Stats

Current price $36.56
Prev. close $36.74
Day low $36.52
Day high $38.17
50-day MA $39.80
200-day MA $44.72
52-week high $60.99
52-week low $33.13
Volume 309,300
Avg. volume 536,451
Dividend yield N/A
Market Cap 993.37M

Esperion Therapeutics, Inc. (ESPR) Company Bio


Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.





ESPR News Stream


Event/Time News Detail
Loading, please wait...

ESPR Social Stream


Loading social stream, please wait...

View Full ESPR Social Stream

ESPR Returns

1-mo -4.82%
3-mo -28.75%
6-mo -16.81%
1-year -23.83%
3-year 225.27%
5-year 131.39%
YTD -20.52%
2018 -30.13%
2017 425.88%
2016 -43.76%
2015 -44.96%
2014 194.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4078 seconds.